Insulin Resistance and Lipid Profile in Non-Obese Women With Prolactinoma Treated With Dopamine Agonists
A cross-sectional study was performed in non-obese premenopausal women with prolactinoma
treated with dopamine agonists evaluated regarding glucose, insulin, Homeostasis Model
Assessment (HOMA), lipid profile, C reactive protein (CRP), body mass index (BMI), waist
circumference, prolactin, estradiol, testosterone, and sex hormone binding globulin (SHBG).
They were compared with control women of similar age and BMI distribution.
Observational Model: Defined Population, Primary Purpose: Screening, Time Perspective: Cross-Sectional, Time Perspective: Prospective
Erika CO Naliato, MSc
Federal University of Rio de Janeiro - Brazil
Brazil: National Committee of Ethics in Research